Abbott to Launch the NeuroSphere myPath Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant

Abbott to Launch the NeuroSphere myPath Digital Health App Designed to Track and Report Pain Relief in Chronic Pain Patients With Physicians Prior to Device Implant
Abbott  today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation or dorsal root ganglion therapy. During the device trial period required before the permanent implant, the app allows patients to record their outcomes on pain and well-being while trialing their …
Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with spinal cord stimulation (SCS) or dorsal root ganglion (DRG) therapy. During the device trial period required before the permanent implant, the app allows patients to record their outcomes on pain and well-being while trialing their neurostimulation therapy.

Related Keywords

United States ,Texas ,Americans ,Abbott Neurosphere ,Pankaj Mehta ,Shachi Patel ,Keith Boettiger ,Linkedin ,Spine Center ,Facebook ,Apple App ,Delmarva Pain ,Neurosphere Digital Care ,Spain Specialists ,Apple App Store ,Chronic Pain Portfolio ,ஒன்றுபட்டது மாநிலங்களில் ,டெக்சாஸ் ,அமெரிக்கர்கள் ,பங்கஜ் மேத்தா ,ஷாச்சி படேல் ,சென்டர் ,முதுகெலும்பு மையம் ,முகநூல் ,ஆப்பிள் செயலி ,டெல்மார்வ வலி ,வலி வல்லுநர்கள் ,ஆப்பிள் செயலி கடை ,நாள்பட்ட வலி போர்ட்‌ஃபோலீயோ ,